CanFaster Publications
The links below open on the respective publication website. In vivo dendritic cell reprogramming for cancer immunotherapy. Authors: Ascic, E., Catena, X., et al. Publication: Science 386, 6719 Year: 2024 Digital PCR quantification of ultrahigh ERBB2 copy number identifies poor breast cancer survival after trastuzumab. Authors: Meng, P., Dalal, H., Chen, Y., Brueffer, C., Gladchuk, S., Alcaide, M.,
https://www.createhealth.lth.se/impact/canfaster/canfaster-publications - 2026-11-15
